ILX-002

N/A

Report date: 2025/03/18 16:34:25
NMEFirst In Class

Base Information

Drug NameILX-002
Drug Alias NameILX002ILX-002
ClassificationOther
Mechanisms of ActionSickle haemoglobin inhibitors
TargetsSickle haemoglobin
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesIllexcor Therapeutics Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A